GeoVax Labs Inc expected to post a loss of $2.78 a share - Earnings Preview

Reuters02-28

* GeoVax Labs Inc is expected to show no change in quarterly revenue when it reports results on February 29 for the period ending December 31 2023

*

* LSEG's mean analyst estimate for GeoVax Labs Inc is for a loss of $2.78 per share.

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

* The mean earnings estimate of analysts was unchanged in the last three months.

* Wall Street's median 12-month price target for GeoVax Labs Inc is $90.00, above its last closing price of $2.36.

Previous quarterly performance (using preferred earnings measure in US dollars).

QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI

ENDING ARTESTIMAT ESTIMATE MET, SE %

E® MISSED

Sep. 30 2023 -3.60 -3.60 -4.80 Missed -33.3

Jun. 30 2023 -2.45 -2.47 -3.30 Missed -33.3

Mar. 31 2023 -3.05 -3.05 -2.25 Beat 26.2

Dec. 31 2022 -3.75 -3.00 -3.00 Met 0

Sep. -1.80 -1.80 -2.55 Missed -41.7

30 2022

Jun. 30 2022 -4.80 -2.70 Beat 43.8

Mar. 31 2022 -4.65 -4.65 -5.10 Missed -9.7

Dec. 31 2021 -6.00

This summary was machine generated February 27 at 21:49 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2414733554?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-02-28 05:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2414733554","market":"us","top_or_hot":-1,"title":"GeoVax Labs Inc    expected to post a loss of $2.78 a share - Earnings Preview","media":"Reuters","content":"<html><body><p>* <a href=\"https://laohu8.com/S/GOVX\">GeoVax Labs Inc</a>     is expected to show no change in quarterly revenue when it reports  results on February 29 for the period ending December 31 2023</p><p>   * </p><p>   * LSEG's mean analyst estimate for <a href=\"https://laohu8.com/S/GOVXW\">GeoVax Labs Inc</a> is for a loss of $2.78 per share. </p><p>   * The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 4 \"strong buy\" or \"buy,\" no \"hold\" and no \"sell\" or \"strong sell.\"  </p><p>   * The mean earnings estimate of analysts was unchanged in the last three months. </p><p>   * Wall Street's median 12-month price target for GeoVax Labs Inc is $90.00, above its last closing price of $2.36. </p><p>Previous quarterly performance (using preferred earnings measure in US dollars). </p><p>QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI</p><p>ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %</p><p>              E®                               MISSED  </p><p>Sep. 30 2023  -3.60       -3.60      -4.80     Missed  -33.3</p><p>Jun. 30 2023  -2.45       -2.47      -3.30     Missed  -33.3</p><p>Mar. 31 2023  -3.05       -3.05      -2.25     Beat    26.2</p><p>Dec. 31 2022  -3.75       -3.00      -3.00     Met     0</p><p>Sep.        -1.80       -1.80      -2.55     Missed  -41.7</p><p>30 2022                                                </p><p>Jun. 30 2022              -4.80      -2.70     Beat    43.8</p><p>Mar. 31 2022  -4.65       -4.65      -5.10     Missed  -9.7</p><p>Dec. 31 2021              -6.00                        </p><p>This summary was machine generated February 27 at 21:49 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GeoVax Labs Inc    expected to post a loss of $2.78 a share - Earnings Preview</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGeoVax Labs Inc    expected to post a loss of $2.78 a share - Earnings Preview\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-02-28 05:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>* GeoVax Labs Inc     is expected to show no change in quarterly revenue when it reports  results on February 29 for the period ending December 31 2023   *    * LSEG's mean analyst estimate for ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GOVX","symbol_name":"GeoVax Labs Inc","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2414733554","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2414733554","pubTimestamp":1709070617,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"* GeoVax Labs Inc     is expected to show no change in quarterly revenue when it reports  results on February 29 for the period ending December 31 2023   *    * LSEG's mean analyst estimate for GeoVax","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"GOVX":"GeoVax Labs Inc"},"translate_title":"GeoVax Labs Inc。预计每股亏损2.78美元——收益预览","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GOVX":0.9},"content_text":"* GeoVax Labs Inc     is expected to show no change in quarterly revenue when it reports  results on February 29 for the period ending December 31 2023   *    * LSEG's mean analyst estimate for GeoVax Labs Inc is for a loss of $2.78 per share.    * The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 4 \"strong buy\" or \"buy,\" no \"hold\" and no \"sell\" or \"strong sell.\"     * The mean earnings estimate of analysts was unchanged in the last three months.    * Wall Street's median 12-month price target for GeoVax Labs Inc is $90.00, above its last closing price of $2.36. Previous quarterly performance (using preferred earnings measure in US dollars). QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRIENDING        ARTESTIMAT  ESTIMATE             MET,    SE %              E®                               MISSED  Sep. 30 2023  -3.60       -3.60      -4.80     Missed  -33.3Jun. 30 2023  -2.45       -2.47      -3.30     Missed  -33.3Mar. 31 2023  -3.05       -3.05      -2.25     Beat    26.2Dec. 31 2022  -3.75       -3.00      -3.00     Met     0Sep.        -1.80       -1.80      -2.55     Missed  -41.730 2022                                                Jun. 30 2022              -4.80      -2.70     Beat    43.8Mar. 31 2022  -4.65       -4.65      -5.10     Missed  -9.7Dec. 31 2021              -6.00                        This summary was machine generated February 27 at 21:49 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2414733554"}